Creating an affordable treatment for drug-resistant tuberculosis in children
Phase II: Development of Low-Cost, Shelf-Stable Treatment for Tuberculosis
This study is working on a new, affordable medicine for kids with a tough type of tuberculosis that doesn't respond to standard treatment, making it easier for them to get the help they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Via Therapeutics, LLC NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-10935742 on NIH RePORTER |
What this research studies
This research focuses on developing a low-cost and shelf-stable drug formulation specifically designed to treat rifampicin-resistant pulmonary tuberculosis in children. The approach involves creating a medication that is easy to administer, making it more accessible for pediatric patients who suffer from this serious condition. The research will include testing the effectiveness and safety of this new treatment in clinical settings, aiming to improve outcomes for young patients affected by tuberculosis.
Who could benefit from this research
Good fit: Ideal candidates for this research are pediatric patients diagnosed with rifampicin-resistant pulmonary tuberculosis.
Not a fit: Patients who do not have rifampicin-resistant tuberculosis or who are adults may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more affordable and effective treatment option for children suffering from drug-resistant tuberculosis.
How similar studies have performed: Other research has shown promise in developing new treatments for tuberculosis, but this specific approach targeting pediatric patients with drug resistance is relatively novel.
Where this research is happening
Austin, United States
- Via Therapeutics, LLC — Austin, United States (Active)
Researchers
- Principal investigator: Warnken, Zachary — Via Therapeutics, LLC
- Study coordinator: Warnken, Zachary
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.